Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02861157 · ClinicalTrials.gov registry record · Phase 2
Mobile Technology & Online Tools to Track Adherence in Chronic Illness Patients
A Phase 2 study, sponsored by 3-C Institute for Social Development.
- Completed
- Registry status
- Phase 2
- Development phase
- 200
- Enrollment target
NCT02861157: Completed Phase 2 study, sponsored by 3-C Institute for Social Development.
NCT02861157 is a Phase 2 study that has completed, run by 3-C Institute for Social Development. The registered enrollment target is 200 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (50% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02861157, a Phase 2 study, has completed, sponsored by 3-C Institute for Social Development.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 200 participants
- Enrollment target
Study Summary
The purpose of this project is to test the efficacy of Planet T1D, a mobile and web-based technology infrastructure specifically designed to (a) enhance youths' type 1 diabetes disease- and treatment-related knowledge through interactive and game-based educational materials; (b) support adherence to the treatment regimen through customized task prompts via mobile and web-based delivery; and (c) promote patient-provider communication through real-world data collection and feedback loops. Investigators will examine the effectiveness of the Planet T1D mobile app and website in improving treatment adherence, disease-related knowledge, transition readiness, condition management, and the psychological correlates of these variables in youth with type 1 diabetes.
Primary Outcome
Both parent and adolescent participants will complete a consultant-created 25 item questionnaire to assess their knowledge of type 1 diabetes.
Interventions
- BEHAVIORAL Planet T1D
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2015-07-01 |
| Est. Completion | 2016-09-12 |
| Phase | Phase 2 |
What the finished NCT02861157 record still lists
NCT02861157 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (50% higher).
The record links to 0 conditions, and to 1 intervention - of which Planet T1D is the first listed.
NCT02861157 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02861157 about?
NCT02861157 is a clinical study titled "Mobile Technology & Online Tools to Track Adherence in Chronic Illness Patients". The purpose of this project is to test the efficacy of Planet T1D, a mobile and web-based technology infrastructure specifically designed to (a) enhance youths' type 1 diabetes disease- and treatment-related knowledge through interactive and game-based educational materials; (b) support adherence to...
What is the current status of trial NCT02861157?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 200 participants. The study started on 2015-07-01. Estimated completion is 2016-09-12.
What interventions are being tested in trial NCT02861157?
The interventions under investigation include: Planet T1D (BEHAVIORAL).
Who is sponsoring clinical trial NCT02861157?
This trial is sponsored by 3-C Institute for Social Development, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02861157's enrollment target sits among peer trials
200 304th of 2000 higher than 1,652 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI